Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Yagen

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Neuropharmacology|August 8, 2006
Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drugEyal Sobol, Boris Yagen, H Steve White, et al.
Epilepsia|March 21, 2002
Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drugNina Isoherranen, H Steve White, Richard H Finnell, et al.
British Journal of Pharmacology|February 25, 2003
Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodentsNina Isoherranen, Boris Yagen, José H Woodhead, et al.
Disease Models & Mechanisms|August 31, 2011
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in DictyosteliumPishan Chang, Benoit Orabi, Rania M Deranieh, et al.
Epilepsia|December 14, 2011
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damageH Steve White, Anitha B Alex, Amanda Pollock, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Neuropharmacology|August 8, 2006
Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drugEyal Sobol, Boris Yagen, H Steve White, et al.
Epilepsia|March 21, 2002
Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drugNina Isoherranen, H Steve White, Richard H Finnell, et al.
British Journal of Pharmacology|February 25, 2003
Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodentsNina Isoherranen, Boris Yagen, José H Woodhead, et al.
Disease Models & Mechanisms|August 31, 2011
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in DictyosteliumPishan Chang, Benoit Orabi, Rania M Deranieh, et al.
Epilepsia|December 14, 2011
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damageH Steve White, Anitha B Alex, Amanda Pollock, et al.
Pageof 5